Streetbeat News

Stock Prices

LEGN

Legend Biotech (NASDAQ:LEGN) has received mixed analyst ratings, with a majority being bullish. The average 12-month price target is $76.7, slightly up from the previous $76.00. The company has shown significant revenue growth but faces challenges with ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 2:00 pm

HLI

Houlihan Lokey (NYSE:HLI) has significantly outperformed the market over the past 5 years, with an annualized return of 29.18%. A $1000 investment in HLI 5 years ago would now be worth $3,521.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 2:00 pm

SPY

The Michigan Consumer Sentiment Index for September came in at 70.1, surpassing the estimated 69.0 and the previous month's 67.9. This indicates a positive shift in consumer sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 2:00 pm

WELL

Welltower (NYSE:WELL) has outperformed the market over the past 20 years with an average annual return of 10.5%, surpassing the market by 2.08% annually. A $100 investment in WELL 20 years ago would now be worth $721.03, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 2:00 pm

MTN

Analysts have mixed ratings for Vail Resorts (NYSE:MTN), with recent adjustments in price targets reflecting varied sentiments. The average 12-month price target has decreased by 7.28% to $203.75. Vail Resorts shows strong financial health with impressive revenue growth, net margin, ROE, and ROA, while maintaining a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 2:00 pm

BNBUSD

Floki has partnered with GraFun, a new meme coin launchpad on Binance Smart Chain, leading to a 16% increase in Floki's token price. Floki will acquire a 40% stake in GraFun and receive 40% of its revenue. The launchpad has secured partnerships with BNB Chain, DeXe Protocol, HOT Protocol, and DWF Labs.

Portfolio Pulse from Murtuza Merchant

September 27, 2024 | 1:59 pm

BMEA

IONQ

RKLB

IonQ, Biomea Fusion, and Rocket Lab USA saw significant stock price increases on Friday. IonQ surged 20% after securing a $54.5 million contract with the US Air Force Research Lab. Biomea Fusion rose 15.5% following the FDA lifting a clinical hold, and Rocket Lab USA gained 11.5% after a price target upgrade.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 1:56 pm

RKLB

An option alert for Rocket Lab USA (RKLB) indicates a sweep of 30 call options for April 17 with a strike price of $17, priced at $0.9 each, with no open interest. This comes ahead of their earnings report on November 6.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:47 pm

MNSO

Traders are circulating an unconfirmed rumor that MINISO's stock has been picked by a popular newsletter service. This speculation is causing attention around MINISO's stock.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:45 pm

FXI

SPY

USO

The August PCE inflation data shows a slowdown, which could impact market expectations for interest rates. Oil prices are under scrutiny due to supply uncertainties caused by Hurricane Helene and Middle East tensions. Chinese stocks are rising, driven by government stimulus efforts.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 1:42 pm